ConductScience.org, home

Paper28606

Mechanism of interferon action. Properties of an interferon-mediated ribonucleolytic activity from mouse L929 cells.

Eppstein DA and 1 other. Virology, 1978. Cited by 49 papers, by iCite.

Cite this record

ConductScience Library. Mechanism of interferon action. Properties of an interferon-mediated ribonucleolytic activity from mouse L929 cells. Papers, record 28606. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28606

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mechanism of interferon action. Properties of an interferon-mediated ribonucleolytic activity from mouse L929 cells.
PubMed
Journal
Virology
PubMed
Year
1978
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
49
iCite
Relative citation ratio, by iCite
1.23
iCite
Revised in PubMed
2019-12-10
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Eppstein DAD A
2Samuel CEC E

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
InterferonsMajor topic
RNA, ViralMajor topic
RibonucleasesMajor topic
Enzyme Activation
Hydrogen-Ion Concentration
L Cells
Magnesium
Potassium
Protein Biosynthesis
RNA
Reoviridae
Viral Proteins

Source PubMed

Download CSV of topics

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 49 citations.

PMIDTitleJournalYearIn PapersSource
27595182New advances in our understanding of the "unique" RNase L in host pathogen interaction and immune signaling.Cytokine2020https://conductscience.org/library/papers/27595182PubMed
26760998The Roles of RNase-L in Antimicrobial Immunity and the Cytoskeleton-Associated Innate Response.Int J Mol Sci2016https://conductscience.org/library/papers/26760998PubMed
17681844A scientific journey through the 2-5A/RNase L system.Cytokine Growth Factor Rev2007https://conductscience.org/library/papers/17681844PubMed
7079179Structural requirements of (2'-5') oligoadenylate for protein synthesis inhibition in human fibroblasts.Nucleic Acids Res1982https://conductscience.org/library/papers/7079179PubMed
6947212
5'-O-Monophosphoryladenylyl(2' goes to 5')adenylyl(2' goes to 5')adenosine is an antagonist of the action of 5'-O-triphosphoryladenylyl-(2' goes to 5')adenylyl(2' goes to 5')adenosine and double-stranded RNA.
Proc Natl Acad Sci U S A1981https://conductscience.org/library/papers/6947212PubMed
6865941Growth regulation of melanoma cells by interferon and (2'-5')oligoadenylate synthetase.Mol Cell Biol1983https://conductscience.org/library/papers/6865941PubMed
6676984Biosynthetic human interferon treatment of herpetic keratitis.Trans Am Ophthalmol Soc1983https://conductscience.org/library/papers/6676984PubMed
6300696Xyloadenosine analogue of (A2'p)2A inhibits replication of herpes simplex viruses 1 and 2.Nature1983https://conductscience.org/library/papers/6300696PubMed
6244560Kinetics of decay in the expression of interferon-dependent mRNAs responsible for resistance to virus.Proc Natl Acad Sci U S A1980https://conductscience.org/library/papers/6244560PubMed
6244537Double-stranded RNA inhibits a phosphoprotein phosphatase present in interferon-treated cells.Proc Natl Acad Sci U S A1980https://conductscience.org/library/papers/6244537PubMed
6167846The interferon renaissance: molecular aspects of induction and action.Microbiol Rev1981https://conductscience.org/library/papers/6167846PubMed
6166003Inhibition of vaccinia mRNA methylation by 2',5'-linked oligo(adenylic acid) triphosphate.Proc Natl Acad Sci U S A1981https://conductscience.org/library/papers/6166003PubMed
424314Metabolic stability of 2' 5'oligo (A) and activity of 2' 5'oligo (A)-dependent endonuclease in extracts of interferon-treated and control HeLa cells.Nucleic Acids Res1979https://conductscience.org/library/papers/424314PubMed
291897Interferon, double-stranded RNA, and RNA degradation: activation of an endonuclease by (2'-5')An.Proc Natl Acad Sci U S A1979https://conductscience.org/library/papers/291897PubMed
284384
Mechanism of interferon action: phosphorylation of protein synthesis initiation factor eIF-2 in interferon-treated human cells by a ribosome-associated kinase processing site specificity similar to hemin-regulated rabbit reticulocyte kinase.
Proc Natl Acad Sci U S A1979https://conductscience.org/library/papers/284384PubMed
228264An interferon-induced phosphodiesterase degrading (2'-5') oligoisoadenylate and the C-C-A terminus of tRNA.Proc Natl Acad Sci U S A1979https://conductscience.org/library/papers/228264PubMed
226962Kinetics of the induction of three translation-regulatory enzymes by interferon.Proc Natl Acad Sci U S A1979https://conductscience.org/library/papers/226962PubMed
114998Increased nuclease activity in cells treated with pppA2'p5'A2'p5' A.Proc Natl Acad Sci U S A1979https://conductscience.org/library/papers/114998PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28606

GET https://conductscience.org/api/papers/v1/28606/authors